Assetmark Inc. Purchases 728 Shares of Ascendis Pharma A/S (NASDAQ:ASND)
Assetmark Inc. raised its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 32.9% in the 4th quarter, ...
Meiragtx Holdings (MGTX) Gets a Buy from Evercore ISI
Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report) on March 14 and set a price ...
Morgan Stanley Reaffirms Their Hold Rating on Ascendis Pharma (ASND)
In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a ...
ETF Daily News6d
Ascendis Pharma A/S (NASDAQ:ASND) Stake Reduced by Rhumbline Advisers
Check Out Our Latest Analysis on Ascendis Pharma A/S Ascendis Pharma A/S Price Performance NASDAQ:ASND opened at $138.18 on Tuesday. The stock has a market cap of $8.39 billion, a P/E ratio of -19 ...
Institutional Investor4d
Biopharma Funds Are in Sick Bay
MoonLake, a clinical-stage biopharma company developing immunology therapeutics, was created by an April 2022 merger with ...
MT Newswires on MSN3d
European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading
European equities traded in the US as American depositary receipts were treading water late Thursday morning, edging 0.1% higher to 1,396.7 on the S&P Europe Select ADR Index. From continental Europe, ...
Yahoo Finance3d
Ascendis Pharma A/S (ASND)
After hours: 7:21:52 p.m. EST Loading Chart for ASND ...
Bloomberg L.P.3d
Ascendis Pharma A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...